Dr. Jim Shelton's Pearls: Oral Emergency Contraceptive

Jim Shelton

CCP | Editor-in-Chief, Global Health Science & Practice

Dr. Jim Shelton's Pearls is an occasional series by USAID’s Global Health Science Advisor that answers commonly asked questions about family planning. 

Originally posted on September 1, 2010.

Question: I understand the FDA has approved a new emergency contraceptive (EC). Can you please tell me about it?

Answer: Yes, on August 13, 2010 the FDA approved ella (ulipristal acetate) as a new oral emergency contraceptive. Some of its attributes:

  •  Ella has a larger window of action – up to 120 hours after unprotected sex, compared to 72 hours for LNG. For either, the sooner the EC is taken, the more effective it is.
  • It is somewhat more effective than the current standard levonorgestrel (LNG) EC. In comparative clinical studies, women using ella had a 1.8% chance of pregnancy after an episode of unprotected coitus compared to 2.6%. (The expected rate of pregnancy is approximately 5.5% had they not used EC.)
  • Ella is a progesterone agonist/antagonist, whereas LNG is a progestin.

 

Comments

Once again feeling happy and proud to say that this is one of my favorite Blogs. The postings are very unique and also outstanding with the new creativity and knowledge and with the new different ideas and concepts.I love the way you have answerd the questions, Really I am waiting for some more new posts from you. Just keep up your higher efficiency